MGLRX | RRGRX | MGLRX / RRGRX | |
Total Expense Ratio | 0.85 | 0.95 | 89% |
Annual Report Gross Expense Ratio | 0.86 | 0.96 | 90% |
Fund Existence | 13 years | 9 years | - |
Gain YTD | 1.057 | 3.714 | 28% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.26B | 158M | 1,430% |
Annual Yield % from dividends | 2.68 | 3.06 | 88% |
Returns for 1 year | 2.37 | 9.68 | 24% |
Returns for 3 years | -6.56 | 2.68 | -245% |
Returns for 5 years | 20.67 | 18.38 | 112% |
Returns for 10 years | 26.78 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LTAGX | 14.91 | 0.04 | +0.27% |
Lord Abbett International Growth R5 | |||
AMIDX | 13.07 | -0.01 | -0.08% |
Amana Developing World Institutional | |||
QCSGX | 18.63 | -0.02 | -0.11% |
Federated Hermes MDT Small Cap Growth C | |||
NEJCX | 6.00 | -0.06 | -0.99% |
Natixis Vaughan Nelson Small Cap C | |||
JFNIX | 63.94 | -0.88 | -1.36% |
Janus Henderson Global Life Sciences I |